Medpace Chairman Troendle Sold ~$125M in Stock Over Six Weeks
MEDP sits 65% above its 52-week low of $373.
Summary
Medpace Chairman and CEO August Troendle sold roughly $125 million in stock over six weeks, extending a pattern of heavy insider selling and reducing his stake to 19.1%.
Key Events · Ownership and Investor Activity · MEDP
-
Chairman Sold ~$125M in Stock
August J. Troendle sold approximately 200,000 shares between August 10 and September 25, 2026, at prices ranging from $600.00 to $637.48, generating roughly $125 million in proceeds.
-
Stake Reduced to 19.1%
Troendle's aggregate beneficial ownership declined to 5,396,508 shares (19.1% of class), with Medpace Investors, LLC holding 4,733,019 shares (16.8%).
-
Extends 90-Day Insider Selling Trend
This sale adds to over $175 million in open-market insider selling over the past 90 days, including a $184.8 million Form 144 filed by Troendle in July and sales by multiple other officers and directors.
-
Sales Executed via Limit Orders
The transactions were executed through limit orders between August 10 and September 25, 2026, not under a pre-arranged 10b5-1 trading plan.
Analysis · MEDP · Industrial Applications And Services
August J. Troendle, Medpace's Chairman and CEO, sold approximately 200,000 shares between August 10 and September 25, 2026, at prices ranging from $600 to $637, generating roughly $125 million in proceeds. This is a substantial insider distribution that extends a pattern of heavy selling by Troendle and other insiders over the past 90 days, totaling over $175 million in open-market sales. The sales were executed via limit orders, not a pre-arranged 10b5-1 plan, and reduced Troendle's aggregate beneficial ownership to 19.1% of the class. While the company reported strong Q2 results in July, the sustained insider selling at these levels may reflect management's view on valuation or personal diversification, and it adds to the overhang on the stock.
How filings like this one have moved
In the 30 days to Sep 30, 2026, 34.7% of the 1013 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.50%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, MEDP was trading at $615.94 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $17.2B. The 52-week trading range was $373.00 to $677.90. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.